Back to User profile » Professor Luca Stingeni
Papers published by Professor Luca Stingeni:
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study
Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, Giofrè C, Dini V, Vispi M, Atzori L, Cattaneo A, Parodi A, Bardazzi F, Stinco G, Dapavo P, Girolomoni G, Musumeci ML, Papini M, Venturini M, Dastoli S, Di Nuzzo S, Fargnoli MC, Pagnanelli G, Bernardini N, Gambini DM, Malagoli P, Mazzatenta C, Peris K, Zalaudek I, Fabbrocini G, Loconsole F, Vassallo C, Pietroleonardo L, Prignano F, Franchi C, Offidani AM, Bonifati C, Di Lernia V, Gigante G, Bartezaghi MS, Franchi M, Ursoleo P, Aloisi E
Clinical, Cosmetic and Investigational Dermatology 2023, 16:3561-3574
Published Date: 12 December 2023
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
Stingeni L, Malara G, Conti A, Di Costanzo L, Carrera CG, Burlando M, Malagoli P, Musumeci ML, Bardazzi F, Brazzelli V, Amerio P, De Simone C, Trevisini S, Balato A, Megna M, Loconsole F, De Felice C, Bartezaghi M, Rausa A, Aloisi E, Orsenigo R, Costanzo A
Clinical, Cosmetic and Investigational Dermatology 2023, 16:27-38
Published Date: 5 January 2023
Atopic Dermatitis and Patient Perspectives: Insights of Bullying at School and Career Discrimination at Work
Stingeni L, Belloni Fortina A, Baiardini I, Hansel K, Moretti D, Cipriani F
Journal of Asthma and Allergy 2021, 14:919-928
Published Date: 21 July 2021
Profile of Baricitinib and Its Potential in the Treatment of Moderate to Severe Atopic Dermatitis: A Short Review on the Emerging Clinical Evidence
Napolitano M, Fabbrocini G, Cinelli E, Stingeni L, Patruno C
Journal of Asthma and Allergy 2020, 13:89-94
Published Date: 31 January 2020